Royal Bank Of Canada reaffirmed their buy rating on shares of Johnson & Johnson (NYSE:JNJ) in a research report report published on Wednesday morning. Royal Bank Of Canada currently has a $138.00 price target on the stock.

Several other research firms have also issued reports on JNJ. Morgan Stanley boosted their target price on Johnson & Johnson from $135.00 to $140.00 and gave the stock an overweight rating in a research report on Wednesday, July 5th. BidaskClub lowered Johnson & Johnson from a strong-buy rating to a buy rating in a research report on Saturday, July 1st. Vetr lowered Johnson & Johnson from a buy rating to a hold rating and set a $128.54 target price for the company. in a research report on Monday, May 1st. Jefferies Group LLC restated a hold rating and set a $140.00 target price on shares of Johnson & Johnson in a research report on Friday, June 16th. Finally, BTIG Research restated a hold rating on shares of Johnson & Johnson in a research report on Wednesday, April 19th. Eleven investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of $133.65.

Johnson & Johnson (NYSE JNJ) opened at 132.15 on Wednesday. Johnson & Johnson has a one year low of $109.32 and a one year high of $137.00. The firm has a 50 day moving average of $130.42 and a 200 day moving average of $122.68. The firm has a market capitalization of $355.99 billion, a PE ratio of 22.21 and a beta of 0.78.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, April 18th. The company reported $1.83 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.77 by $0.06. The firm had revenue of $17.77 billion during the quarter, compared to analysts’ expectations of $18.02 billion. Johnson & Johnson had a return on equity of 26.50% and a net margin of 22.87%. The company’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.68 EPS. Equities analysts forecast that Johnson & Johnson will post $7.10 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Royal Bank Of Canada Reiterates Buy Rating for Johnson & Johnson (JNJ)” was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/07/18/royal-bank-of-canada-reiterates-buy-rating-for-johnson-johnson-jnj.html.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Tuesday, August 29th will be given a $0.84 dividend. The ex-dividend date of this dividend is Friday, August 25th. This represents a $3.36 annualized dividend and a dividend yield of 2.54%. Johnson & Johnson’s dividend payout ratio is presently 56.47%.

A number of institutional investors have recently added to or reduced their stakes in the company. CWM LLC increased its position in Johnson & Johnson by 1.3% in the second quarter. CWM LLC now owns 15,593 shares of the company’s stock worth $2,063,000 after buying an additional 195 shares during the period. Canal Capital Management LLC increased its position in Johnson & Johnson by 6.9% in the second quarter. Canal Capital Management LLC now owns 15,835 shares of the company’s stock worth $2,095,000 after buying an additional 1,020 shares during the period. TNB Financial increased its position in Johnson & Johnson by 14.0% in the second quarter. TNB Financial now owns 31,472 shares of the company’s stock worth $4,163,000 after buying an additional 3,873 shares during the period. Advisors Capital Management LLC increased its position in Johnson & Johnson by 6.8% in the second quarter. Advisors Capital Management LLC now owns 76,701 shares of the company’s stock worth $10,147,000 after buying an additional 4,891 shares during the period. Finally, Windward Capital Management Co. CA increased its position in Johnson & Johnson by 2.4% in the second quarter. Windward Capital Management Co. CA now owns 90,750 shares of the company’s stock worth $12,005,000 after buying an additional 2,153 shares during the period. 66.02% of the stock is owned by hedge funds and other institutional investors.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Analyst Recommendations for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.